Speaker illustration

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study

Event: ESC Congress 2021 - The Digital Experience

Topic: Scores

Session: Risk Factors and Prevention ePosters

Thumbnail

Oral anticoagulation therapy with rivaroxaban in elderly patients with atrial fibrillation. Results from EMIR study.

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Estimated effect of NOACs compared to Vitamin K Antagonists in real-world atrial fibrillation patients: Data from FANTASIA Registry.

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 6

Thumbnail

One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Insights from acute coronary syndrome registries

Thumbnail

Validation of Charlson Comorbidity Index to predict adverse events in elderly patients with Atrial Fibrillation and Acute Coronary Syndrome: an analysis from LONGEVO-SCA Registry.

Event: ESC CONGRESS 2019

Topic: Prevention

Session: Epidemiology

Thumbnail

Relationship of Charlson Comorbidity Index with adverse events in elderly patients with Acute Coronary Syndromes: an analysis from LONGEVO-SCA Registry.

Event: ESC CONGRESS 2019

Topic: Epidemiology

Session: Cardiovascular disease in the elderly

Thumbnail

Frailty assessment in atrial fibrillation patients with acute coronary syndromes: a subanalysis from LONGEVO-SCA registry

Event: ESC CONGRESS 2019

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly

Thumbnail

Impact of frailty addition in ischemic and bleeding risk scores in elderly patients with Atrial Fibrillation and Acute Coronary Syndrome: a subanalysis from LONGEVO-SCA registry

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes – Epidemiology, Prognosis, Outcome

Thumbnail

Cardiovascular outcomes in patients with Acute Coronary Syndrome and previous cardiovascular disease. An analysis from ACHILLES Registry

Event: ESC CONGRESS 2019

Topic: Peripheral Artery Disease

Session: Comorbidities and prognosis in peripheral artery disease

Thumbnail

Long term cardiovascular risk prediction in Real-World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry.

Event: ESC Congress 2018

Topic: Scores

Session: Secondary prevention

Thumbnail

This platform is supported by

logo Novo Nordisk